Viewing StudyNCT00450983



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00450983
Status: TERMINATED
Last Update Posted: 2017-05-24
First Post: 2007-03-20

Brief Title: Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation Thiotepa Fludarabine and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Graft Versus Host Disease
Leukemia
Keywords:
Name View
childhood myelodysplastic syndromes View
graft versus host disease View
adult acute lymphoblastic leukemia in remission View
recurrent adult acute lymphoblastic leukemia View
childhood acute lymphoblastic leukemia in remission View
recurrent childhood acute lymphoblastic leukemia View
adult acute myeloid leukemia with 11q23 MLL abnormalities View
adult acute myeloid leukemia in remission View
recurrent adult acute myeloid leukemia View
childhood acute myeloid leukemia in remission View
recurrent childhood acute myeloid leukemia View
secondary acute myeloid leukemia View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View
accelerated phase chronic myelogenous leukemia View
blastic phase chronic myelogenous leukemia View
childhood chronic myelogenous leukemia View
relapsing chronic myelogenous leukemia View
adult acute myeloid leukemia with inv16p13q22 View
adult acute myeloid leukemia with t1517q22q12 View
adult acute myeloid leukemia with t1616p13q22 View
adult acute myeloid leukemia with t821q22q22 View